Primary hyperaldosteronism history and symptoms

Revision as of 00:59, 20 July 2017 by Skazmi (talk | contribs)
Jump to navigation Jump to search

Primary hyperaldosteronism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary Hyperaldosteronism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

CT scan Findings

MRI Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Primary hyperaldosteronism history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary hyperaldosteronism history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary hyperaldosteronism history and symptoms

CDC on Primary hyperaldosteronism history and symptoms

Primary hyperaldosteronism history and symptoms in the news

Blogs on Primary hyperaldosteronism history and symptoms

Directions to Hospitals Treating Conn syndrome

Risk calculators and risk factors for Primary hyperaldosteronism history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The hallmark of primary hyperaldosteronism is resistant hypertension. A positive history of sponatneous or unprovoked hypokalemia and treatment-resitant/refractory hypertension are suggestive of primary hyperaldosteronism. The most common symptoms of primary hyperaldosteronism include headaches, facial flushing, vision changes and weakness.

History

Primary hyperaldosteronism may be suspected in the following scenarios:

  • Patients with a history of spontaneous or unprovoked hypokalemia along with hypertension.
  • Patients who develop severe and/or persistent hypokalemia while on low to moderate doses of potassium-wasting diuretics.
  • Patients with a history of treatment-refractory/-resistant hypertension (HTN).

Patients with profound hypokalemia report fatigue, muscle weakness, cramping, headaches, and palpitations. They can also have polydipsia and polyuria from hypokalemia-induced nephrogenic diabetes insipidus. Long-standing HTN may lead to cardiac, retinal, renal, and neurologic problems, with all the associated symptoms and signs. Patients with primary aldosteronism may have subclinical systolic dysfunction, more bradycardia, higher blood pressure and vascular resistance values than those with the secondary hyperaldosteronism. Plasma renin activity has been found to be lower in primary than in secondary hyperaldosteronism.

Common Symptoms

Common symptoms of Conn's syndrome (primary hyperaldosteronism) include:

Hypertension related symptoms

  • Headaches
  • Facial flushing
  • Weakness
  • Visual impairment
  • Impaired consciousness
  • Seizures (hypertensive encephalopathy)

Hypokalemia related symptoms

  • Constipation
  • Polyuria and polydipsia (because of impaired renal concentrating ability)
  • Weakness

Less Common Symptoms

Less common symptoms of Conn's syndrome (primary hyperaldosteronism) include:

  • Paralysis
  • Palpitations
  • Ileus

References

Template:WH Template:WS